Patch Shortage, Heart Risk, and the Cancer Question That Won't Go Away
The FDA's removal of black box warnings has triggered an estrogen patch shortage, new research links early menopause to significantly higher heart disease risk, and a promising study suggests vaginal estrogen may be safe for breast cancer survivors. Key Takeaways: • FDA removed black box warnings from HRT — demand surged and estrogen patches are now in short supply • Women entering menopause before age 45 face 40% higher cardiovascular disease risk • New PubMed research suggests vaginal estrogen does not increase cancer recurrence in breast cancer survivors Sources & References: • Estrogen…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.